New: 100 biomarkers for $190
Lipfendra (enlicitide), the first oral PCSK9 inhibitor, lowers LDL by 60%

Lipfendra (enlicitide), the first oral PCSK9 inhibitor, lowers LDL by 60%

A daily pill that lowers LDL as much as the injections. The FDA approved it today, and it could finally get PCSK9-level lowering to the millions of people who never started a shot.

• Brandon Ballinger